Xiying Yu - Concepedia

Author

Xiying Yu

Chinese Academy of Medical Sciences & Peking Union Medical College ORCID

Also Known As

Wei Jiang, X.-R. Yu, XIYING YU, Xi-Ying Yu, Xiying Yu, Xi‐Ying Yu

Publications

663

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College Beijing Chao-Yang Hospital First Affiliated Hospital of Zhengzhou University Capital Medical University Tianjin Normal University

About

Xiying Yu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	436
2	Cell Biology	8	8	390
3	Health Sciences	2	2	111
4	Natural Sciences	1	1	72
5	Immunology	1	1	46

Xiying Yu

Publications

588

Citations

H-Index

Page 1

	Year	Citations
Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth <i>in vitro</i> and <i>in vivo</i> Linwei Li, Xiying Yu, Yang Yang, International Journal of Cancer Esophageal CancerPathologyCancer BiologyTumor BiologyEcrg4 Gene	2009	93
miR-203 Inhibits the Proliferation and Self-Renewal of Esophageal Cancer Stem-Like Cells by Suppressing Stem Renewal Factor <i>Bmi-1</i> Xiying Yu, Xingran Jiang, Hongxia Li, Stem Cells and Development Stem Cell BiologyCancer BiologyCancer Stem-like CellsTumor BiologyEscc Stem-like Cells	2013	88
MicroRNA‐1322 regulates <i>ECRG2</i> allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma Tengfei Zhang, Dan Zhao, Qiming Wang, Molecular Carcinogenesis Short Tandem RepeatEsophageal CancerPotential BiomarkerPathologyPaired Escc	2012	72
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody‐based therapy Xiaobing Wang, Xingran Jiang, Xiying Yu, Cancer Science Esophageal CancerHealthy SubjectsImmunologyPotential BiomarkerPathology	2013	46
53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells Ruoxi Hong, Fei Ma, Weimin Zhang, BMC Cancer	2016	36
Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway Hongjun Fan, Xiying Yu, Zhigeng Zou, Carcinogenesis	2018	36
RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death Xingran Jiang, Xiying Yu, Jin‐Hu Fan, Cancer Letters Tumor BiologyEsophageal CancerOncogenic AgentMedicineCell Death	2014	35
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9 Xinxin Zhang, Xiying Yu, Zhenguo Zhao, Bone Bone Morphogenic ProteinMedicineBreast CancerMicrorna DetectionSmall Rna	2019	33
Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma Xiying Yu, Hongjun Fan, Xingran Jiang, Oncology Letters	2020	33
DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma Jianjuan Ma, Xiying Yu, Liping Guo, Oncology Letters Tumor BiologyEsophageal CancerMedicineApoptosisDual-specificity Phosphatase 6	2013	24

Page 1